Clinical Trial Update: HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA）for Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 1/2 trial evaluating HepaSphere Interventional Therapy using Digital Subtraction Angiography for breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HepaSphere Interventional Therapy

Snippet

Sponsor: Fuda Cancer Hospital, Guangzhou | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED